2 weeks Ago By Defense World Staff
Rhumbline Advisers decreased its holdings in shares of PetMed Express, Inc. ( NASDAQ:PETS – Free Report ) by 59.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
The firm owned 16,620 shares of the company’s stock after selling 24,077 shares during the period. Rhumbline Advisers owned approximately 0.08% of PetMed Express worth $67,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of PETS. Vanguard Group Inc. increased its position in shares of PetMed Express by 0.
8% in the first quarter. Vanguard Group Inc. now owns 1,186,485 shares of the company’s stock valued at $5,683,000 after buying an additional 9,226 shares in the last quarter.
Oak Thistle LLC purchased a new position in shares of PetMed Express during the 1st quarter worth $50,000. SG Americas Securities LLC acquired a new stake in shares of PetMed Express during the second quarter worth $46,000. BNP Paribas Financial Markets grew its position in shares of PetMed Express by 22.
8% in the first quarter. BNP Paribas Financial Markets now owns 66,501 shares of the company’s stock valued at $319,000 after purchasing an additional 12,326 shares during the period. Finally, Pinnacle Wealth Planning Services Inc.
acquired a new position in PetMed Express in the first quarter valued at $61,000. 73.33% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades A number of equities research analysts have issued reports on PETS shares. Morgan Stanley lowered their price target on PetMed Express from $6.50 to $3.
50 and set an “underweight” rating for the company in a research report on Wednesday, June 12th. Lake Street Capital reiterated a “hold” rating and issued a $3.50 price objective (down previously from $7.
00) on shares of PetMed Express in a report on Wednesday, August 7th. PetMed Express Price Performance PETS opened at $3.68 on Tuesday.
The business has a 50 day moving average price of $3.44 and a two-hundred day moving average price of $3.98.
The company has a market capitalization of $75.83 million, a price-to-earnings ratio of -9.44 and a beta of 0.
71. PetMed Express, Inc. has a 1-year low of $2.
90 and a 1-year high of $11.20. PetMed Express ( NASDAQ:PETS – Get Free Report ) last released its quarterly earnings data on Tuesday, August 6th.
The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.
30. PetMed Express had a negative return on equity of 3.44% and a negative net margin of 1.
24%. The business had revenue of $67.95 million during the quarter, compared to analyst estimates of $77.
52 million. Equities analysts expect that PetMed Express, Inc. will post 0.
08 EPS for the current fiscal year. PetMed Express Profile ( Free Report ) PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. Featured Stories Five stocks we like better than PetMed Express What Are Trending Stocks? Trending Stocks Explained TJX Stock: A Buying Opportunity Before the Holiday Rush What Is WallStreetBets and What Stocks Are They Targeting? Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge Insider Selling Explained: Can it Inform Your Investing Choices? Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter .
.
